By InvitationNot Applicable

Efficacy of Higher Dose Enteral Vitamin D Supplementation in Preterm 28 - 34 Weeks of Gestational Age

Indonesia54 participantsStarted 2024-07-17

Plain-language summary

The goal of this clinical trial is to learn about the effective dosage of enteral vitamin D supplementation in preterm infants with gestational age fom 28 to 34 weeks. The main questions it aims to answer is: \- Does higher dose of enteral vitamin D supplementation (800IU/day) increase vitamin D level better than standard recommended dose (400IU/day) to achieve sufficient level of vitamin D? Participants will: * Take the enteral vitamin D supplementation every fay for 28 days * Have their blood level of vitamin D examined before and after supplementation for 28 days

Who can participate

Age range28 Weeks – 34 Weeks

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * neonates with gestational age 28-34 weeks * tolerated enteral feedings more than 30ml/kg Exclusion Criteria: * infants with major congenital anomaly * infants with gastrointestinal obstruction * infants with congenital renal failure * infants with cholestassis

What they're measuring

25(OH)D level

Timeframe: From enrollment to the end of treatment at 4 weeks

Trial details

NCT IDNCT06674122

SponsorIndonesia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-02-28

View on ClinicalTrials.gov More Vitamin D Supplementation trials